Mengivac (A + C)

What is it?

A vaccine preparation containing inactivated surface antigen of meningitis A and C. It is produced as a powder in vials, with diluent, containing 501g of both group A and group C polysaccharide antigens of Neisseria meningitidis.

Medical Uses

Immunization against meningitis, types A and C.

Dosage

Adults and children over eighteen months, 0.5ml by deep subcutaneous or intramuscular injection.

Special Care

Pregnancy, breastfeeding.

Avoid Use

Patients with severe infections and feverish illnesses.

Possible Drug and Food Interactions

Agents which suppress the immune system.

Known Side Effects

Local skin reactions, slight fever.

Manufacturer

Aventis Pasteur MSD